189 related articles for article (PubMed ID: 10715304)
1. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.
Fandi A; Bachouchi M; Azli N; Taamma A; Boussen H; Wibault P; Eschwege F; Armand JP; Simon J; Cvitkovic E
J Clin Oncol; 2000 Mar; 18(6):1324-30. PubMed ID: 10715304
[TBL] [Abstract][Full Text] [Related]
2. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.
Hasbini A; Mahjoubi R; Fandi A; Chouaki N; Taamma A; Lianes P; Cortès-Funes H; Alonso S; Armand JP; Cvitkovic E; Raymond E
Ann Oncol; 1999 Apr; 10(4):421-5. PubMed ID: 10370784
[TBL] [Abstract][Full Text] [Related]
5. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy.
Bachouchi M; Cvitkovic E; Azli N; Gasmi J; Cortes-Funes H; Boussen H; Rahal M; Kalifa C; Schwaab G; Eschwege F
J Natl Cancer Inst; 1990 Apr; 82(7):616-20. PubMed ID: 1690306
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
Boussen H; Cvitkovic E; Wendling JL; Azli N; Bachouchi M; Mahjoubi R; Kalifa C; Wibault P; Schwaab G; Armand JP
J Clin Oncol; 1991 Sep; 9(9):1675-81. PubMed ID: 1714951
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
;
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
[TBL] [Abstract][Full Text] [Related]
8. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
[TBL] [Abstract][Full Text] [Related]
9. Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients.
Pao WJ; Hustu HO; Douglass EC; Beckford NS; Kun LE
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):299-305. PubMed ID: 2473970
[TBL] [Abstract][Full Text] [Related]
10. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
11. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type.
Azli N; Armand JP; Rahal M; Wibault P; Boussen H; Eschwege F; Schwaab G; Gasmi J; Bachouchi M; Cvitkovic E
Eur J Cancer; 1992; 28A(11):1792-7. PubMed ID: 1382499
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
Cvitkovic E; Bachouchi M; Armand JP
Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
[TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carcinoma in children: retrospective review of 50 patients.
Ayan I; Altun M
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):485-92. PubMed ID: 8655371
[TBL] [Abstract][Full Text] [Related]
15. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
[TBL] [Abstract][Full Text] [Related]
16. [Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities].
Frikha M; Toumi N; Ghorbel L; Ben Salah H; Khabir A; Karray H; Gargouri R; Boudawara T; Ghorbel A; Daoud J
Cancer Radiother; 2010 Jun; 14(3):169-75. PubMed ID: 20347607
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
[TBL] [Abstract][Full Text] [Related]
19. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
[TBL] [Abstract][Full Text] [Related]
20. High-dose epirubicin and cisplatin in locally advanced undifferentiated nasopharyngeal carcinoma.
Onat H; Basaran M; Esassolak M; Bavbek SE; Anacak Y; Kaytan E; Altun M; Haydaroglu A
Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):449-54. PubMed ID: 12512965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
